These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 36935975)

  • 1. The influence mechanism of interlocking director network on corporate risk-taking from the perspective of network embeddedness: Evidence from China.
    Li H; Li Y; Sun Q
    Front Psychol; 2023; 14():1062073. PubMed ID: 36935975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of subscribing to directors' and officers' liability insurance on corporate financialization: Evidence from China.
    Peng C; Fu W; Zhang X; Jiang H
    Front Psychol; 2022; 13():986135. PubMed ID: 36186362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does digital finance promote corporate social responsibility of pollution-intensive industry? Evidence from Chinese listed companies.
    Xin D; Yi Y; Du J
    Environ Sci Pollut Res Int; 2022 Dec; 29(56):85143-85159. PubMed ID: 35790640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of CEO Narcissism and Corporate R&D Investment.
    Wang L; Li H; Mu Y
    Front Psychol; 2022; 13():888618. PubMed ID: 35645881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Managerial Reputation and Risk-Taking on Enterprise Innovation Investment From the Perspective of Social Capital: Evidence From China.
    Wang S; Zhao S; Shao D; Fan X; Zhang B
    Front Psychol; 2022; 13():931227. PubMed ID: 35874409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does Signing Auditor's Reputational Promotion Ease the Financing Constraints of Audited Firms?
    Gu C; Zhao R
    Comput Intell Neurosci; 2022; 2022():3286181. PubMed ID: 35965769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corporate social responsibility, debt financing cost and enterprise innovation.
    Yao JJ; Qi YA; Guo B
    Sci Rep; 2022 Dec; 12(1):21909. PubMed ID: 36535966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does employee stock ownership plan have monitoring and incentive effects? --An analysis based on the perspective of corporate risk taking.
    Zhou Q; Han H; Han J
    Heliyon; 2024 Jan; 10(2):e24489. PubMed ID: 38298652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tax preference, financing constraints and enterprise investment efficiency-Experience, of China's enterprises investment.
    Zhai L; Feng Y; Li F; Zhai L
    PLoS One; 2022; 17(9):e0274336. PubMed ID: 36137158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of the opening of high-speed rail on corporate financing constraints.
    Liao Y; Qiu X; Sun Q; Li P
    PLoS One; 2022; 17(6):e0268994. PubMed ID: 35666715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Environmental Regulation, Corporate Social Responsibility (CSR) Disclosure and Enterprise Green Innovation: Evidence from Listed Companies in China.
    Xu X; Jing R; Lu F
    Int J Environ Res Public Health; 2022 Nov; 19(22):. PubMed ID: 36429491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corporate financialization, financing constraints, and innovation efficiency-Empirical evidence based on listed Chinese pharmaceutical companies.
    Zhu J; Tang Y; Wei Y; Wang S; Chen Y
    Front Public Health; 2023; 11():1085148. PubMed ID: 37124778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Financing constraints and impact on corporate performance growth: Study in China listed logistics enterprises.
    Liu K; Wang Z; Du R; Chen H; Li Y
    PLoS One; 2023; 18(6):e0285671. PubMed ID: 37379297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Digital transformation and enterprise resilience: Enabling or burdening?
    Li C; Wang Y
    PLoS One; 2024; 19(7):e0305615. PubMed ID: 39028736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Green finance and corporate environmental responsibility: evidence from heavily polluting listed enterprises in China.
    He L; Zhong T; Gan S
    Environ Sci Pollut Res Int; 2022 Oct; 29(49):74081-74096. PubMed ID: 35643997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Environmental Pollution Liability Insurance of Health Risk and Corporate Environmental Performance: Evidence From China.
    Wu W; Zhang P; Zhu D; Jiang X; Jakovljevic M
    Front Public Health; 2022; 10():897386. PubMed ID: 35832274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Digital Transformation on Enterprise Green Innovation: Effect and Transmission Mechanism.
    Feng H; Wang F; Song G; Liu L
    Int J Environ Res Public Health; 2022 Aug; 19(17):. PubMed ID: 36078329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tax Incentives, Tax Enforcement, and Enterprise R&D Investment: Evidence From Chinese A-Share Listed.
    Sun Y
    Front Psychol; 2022; 13():953313. PubMed ID: 35874375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Empirical Analysis of Customer Risk and Corporate Financing Constraints Based on Supply Chain Networks.
    Bao Q; Wang JY; Xie R; Cai ZQ
    Comput Intell Neurosci; 2022; 2022():7984852. PubMed ID: 36156976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does digital finance improve the green investment of Chinese listed heavily polluting companies? The perspective of corporate financialization.
    Jiang Y; Guo C; Wu Y
    Environ Sci Pollut Res Int; 2022 Oct; 29(47):71047-71063. PubMed ID: 35595899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.